At UR Anoop Group, we are pioneering next-generation drug delivery systems focused on overcoming the challenges of the blood-brain barrier (BBB). Our patented technology enables precise, non-invasive transport of therapeutics to the brain, offering new hope for treating complex neurological disorders. Driven by a commitment to scientific excellence and patient outcomes, our multidisciplinary team bridges medicine, engineering, and innovation. We are currently advancing a robust research pipeline aimed at neurodegenerative diseases and brain tumors. Through global collaborations and a strong IP foundation, we aspire to transform the future of brain health.